finance

Johnson & Johnson to pay $230m to settle opioid claim

[ad_1]

“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business – not only in New York, but across the entire country,” she added, saying her focus remained “getting funds into communities devastated by opioids as quickly as possible.”

[ad_2]

READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more